Optimisation of the formulation of AmacaGel for therapeutic applications

点击翻译按钮获取中文摘要

AmacaThera is a drug and cell delivery company based in Toronto developing a unique biomaterial technology - AmacaGel - for drug and cell delivery-based medical applications. The company would like to partner with the scientist of the Technology Access Center in Bio-Innovation from the college La Cité in Ottawa to deliver cell-based therapies to treat traumatic brain injury, blindness, and spinal cord injury and other high-unmet need indications using their technology. The aim of the project is to screen various excipients that can be combined with AmacaGel to support long-term cryo-storage of the cell-gel products.